Trelegy Ellipta Will Be the First 3-in-1 Inhaler for COPD

Trelegy Ellipta (TREL-eh-gee) will be the first "three-in-one" inhaler for COPD.

Trelegy combines two long-acting inhaled bronchodilators, umeclidinium and vilanterol...and the corticosteroid, fluticasone furoate. It's a dry-powder inhaler that's given as a single puff once daily.

Expect Trelegy to be saved for COPD patients who have exacerbations while taking two long-acting bronchodilators...or who also have asthma.

Get unlimited access through an Enterprise license

Hospital Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals